Literature DB >> 14744625

Inhibition of basal and interleukin-1-induced VCAM-1 expression by phospholipid hydroperoxide glutathione peroxidase and 15-lipoxygenase in rabbit aortic smooth muscle cells.

Antje Banning1, Kerstin Schnurr, Gaby Fleur Böl, Dagmar Kupper, Katrin Müller-Schmehl, Helena Viita, Seppo Ylä-Herttuala, Regina Brigelius-Flohé.   

Abstract

Cytokines or hydroperoxides upregulate cell adhesion molecules (CAM) in early stages of atherosclerosis. VCAM-1 expression was therefore investigated in rabbit aortic smooth muscle cells (SMC) stably transfected either with phospholipid hydroperoxide glutathione peroxidase (PHGPx; SMCPHGPx) as a hydroperoxide-reducing enzyme or with 15-lipoxygenase (15-LOX; SMCLOX) as a hydroperoxide-producing enzyme. Transfected cells showed up to 3-fold enhanced PHGPx and a marked LOX activity, respectively, that was absent in controls. Intracellular hydroperoxides were 6-fold higher in SMCLOX than in SMC or SMCPHGPx. Intracellular protein thiols were decreased by 50 and 90% in SMCPHGPx and SMCLOX, respectively. Glutathione mixed disulfides were tentatively increased from SMC via SMCPHGPx to SMCLOX, accordingly. Thiol reduction with tris(2-carboxyethyl)phosphine completely restored protein thiols in SMCPHGPx, whereas in SMCLOX only 60% of control values were recovered. Basal VCAM-1 mRNA levels were decreased by 50% in SMCPHGPx and 75% in SMCLOX. VCAM-1-inducibility was abrogated in SMCLOX but not in SMCPHGPx. Accordingly, NFkappaB-driven reporter gene activation by IL-1 was unaffected in SMCPHGPx but abolished in SMCLOX. The data confirm that PHGPx overexpression dampens CAM expression either by lowering stimulatory hydroperoxides or by using hydroperoxides for protein modification. But hydroperoxides, when constitutively overproduced as in SMCLOX, inhibit CAM expression and render cells refractory to IL-1 stimulation likely due to oxidation of protein thiols of the signaling system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744625     DOI: 10.1016/j.freeradbiomed.2003.10.027

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

Review 1.  Ferroptosis and kidney diseases.

Authors:  Shumei Tang; Xiangcheng Xiao
Journal:  Int Urol Nephrol       Date:  2019-11-25       Impact factor: 2.370

Review 2.  Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants.

Authors:  Joan M Cook-Mills; Michelle E Marchese; Hiam Abdala-Valencia
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

3.  The GI-GPx gene is a target for Nrf2.

Authors:  Antje Banning; Stefanie Deubel; Dirk Kluth; Zewen Zhou; Regina Brigelius-Flohé
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

Review 4.  Selenoproteins and cardiovascular stress.

Authors:  Aaron H Rose; Peter R Hoffmann
Journal:  Thromb Haemost       Date:  2014-10-30       Impact factor: 5.249

5.  Overexpression of antioxidant enzymes in ApoE-deficient mice suppresses benzo(a)pyrene-accelerated atherosclerosis.

Authors:  Hong Yang; LiChun Zhou; Zefen Wang; L Jackson Roberts; Xinghua Lin; Yanfeng Zhao; ZhongMao Guo
Journal:  Atherosclerosis       Date:  2009-04-11       Impact factor: 5.162

6.  Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice.

Authors:  ZhongMao Guo; Qitao Ran; L Jackson Roberts; Lichun Zhou; Arlan Richardson; Chakradhari Sharan; DongFan Wu; Hong Yang
Journal:  Free Radic Biol Med       Date:  2007-10-02       Impact factor: 7.376

7.  The Roles of Glutathione Peroxidases during Embryo Development.

Authors:  Christoph Ufer; Chi Chiu Wang
Journal:  Front Mol Neurosci       Date:  2011-07-28       Impact factor: 5.639

8.  Involvement of the Antioxidant Effect and Anti-inflammatory Response in Butyrate-Inhibited Vascular Smooth Muscle Cell Proliferation.

Authors:  Omana P Mathew; Kasturi Ranganna; Shirlette G Milton
Journal:  Pharmaceuticals (Basel)       Date:  2014-11-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.